<DOC>
	<DOCNO>NCT00004660</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate effect 20 Gy external-beam radiotherapy 1 orbit vs. untreated orbit 3 6 month therapy patient Graves ' ophthalmopathy . II . Evaluate whether 20 Gy external-beam radiotherapy deliver second orbit 6 month later course disease produce effect equal magnitude observe first orbit treat . III . Relate magnitude treatment effect time since onset eye symptom . IV . Evaluate whether characteristic radiation retinopathy present 3 year orbital radiotherapy .</brief_summary>
	<brief_title>Phase II Randomized Controlled Study Sequential Orbital Radiotherapy Graves ' Ophthalmopathy</brief_title>
	<detailed_description>PROTOCOL OUTLINE : The posterior region 1 orbit irradiate 2 week supervoltage equipment . The orbit treat 6 month later . The sequence therapy randomly assign . The untreated eye receive simultaneous sham treatment radiotherapy session . Patients follow 3 , 6 , 9 , 12 , 36 month .</detailed_description>
	<mesh_term>Graves Disease</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Firm diagnosis Graves ' disease normal thyroid function , i.e . : Thyroidstimulating immunoglobulin positive Thyroxine 512.5 micrograms/dL Triiodothyronine 80180 nanograms/dL Thyroidstimulating hormone 0.28 mIU/L Euthyroid due therapy acceptable Ophthalmopathy meeting least 3 follow criterion : Chemosis lid edema Lid lag , lid retraction , restrictive lagophthalmos Proptosis least 20 mm Krahn exophthalmometry least 1 eye Less 4 mm discrepancy eye Patient perception `` stare '' `` bulge '' Extraocular muscle motion restriction 1 eye clinical exam patient report diplopia extremes gaze Extraocular muscle enlargement computerize tomography ( previous study result acceptable ) Mild moderate ophthalmopathy , i.e . : Orbital pain Lacrimation Photophobia Visual blurring diplopia No optic neuropathy , i.e . : Afferent pupillary defect Impaired color vision D15 testing ( unless congenital color perception deficiency ) Visual field defect Impaired visual acuity No corneal ulcer Prior/Concurrent Therapy No prior externalbeam radiotherapy head neck At least 2 week since corticosteroid Patient Characteristics No prior head neck tumor No diabetes No pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1999</verification_date>
	<keyword>Graves ' disease</keyword>
	<keyword>thyroid disease</keyword>
	<keyword>endocrine disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>